They significantly reduced the expression of the SPHK1 mRNA (Figure 1A) and protein (Figure 1B and Supplementary Figure S1) and significantly inhibited proliferation in both the CNE-1 and CNE-2 NPC cell line (Figure 1C and 1D). The gene discussed is SPHK1; the disease is nasopharyngeal carcinoma.